New System Incorporates Latest in Automation Technology
The XN-9000, a scalable, configurable automation system, integrates multiple XN modules, including the Sysmex RU-20™ concentrated reagent dilution unit; sample sorting and archiving provided by the PVT LabSystems® TS-500; WAM™ decision support software; and Bio-Rad's VARIANT™ II TURBO Link for on-demand HbA1c testing.
With its new system, Mercy will also perform:
XN-9000 Plays Critical Role in Determining Diabetes Control
The XN-9000 uses HPLC (high-performance liquid chromatography) technology – the gold standard for HbA1c testing – to perform HbA1c analysis, which measures the amount of glucose attached to the hemoglobin in the red blood cell and estimates blood glucose control during the previous three to four months.
According to the American Diabetes Association, diabetes affects more than 25 million children and adults in the United States, or 8.3 percent of the population. It can increase a person's risk for developing serious complications, including heart disease and stroke, high blood pressure, blindness, kidney and nervous system diseases. Proper management of the chronic condition can delay or even prevent the onset of complications, allowing patients to live healthier, more pr
|SOURCE MERCY MEDICAL CENTER|
Copyright©2012 PR Newswire.
All rights reserved